Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD
Market Cap: $575.6m

Accolade Inc
PP&E Net

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Accolade Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
PP&E Net
$43.2m
CAGR 3-Years
53%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
PP&E Net
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
12%
CVS Health Corp
NYSE:CVS
PP&E Net
$28.1B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
11%
Cigna Corp
NYSE:CI
PP&E Net
$3.7B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
9%
Laboratory Corporation of America Holdings
NYSE:LH
PP&E Net
$3.1B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
6%
Guardant Health Inc
NASDAQ:GH
PP&E Net
$304.8m
CAGR 3-Years
-4%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Accolade Inc
Glance View

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

ACCD Intrinsic Value
8.24 USD
Undervaluation 15%
Intrinsic Value
Price $7.02

See Also

What is Accolade Inc's PP&E Net?
PP&E Net
43.2m USD

Based on the financial report for Nov 30, 2024, Accolade Inc's PP&E Net amounts to 43.2m USD.

What is Accolade Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
30%

Over the last year, the PP&E Net growth was -10%. The average annual PP&E Net growth rates for Accolade Inc have been 53% over the past three years , 30% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett